Biomarkers implicated in lower urinary tract symptoms: Systematic review and pathway analyses

Nazema Y. Siddiqui, Brian T. Helfand, Victor P. Andreev, Joseph T. Kowalski, Megan S. Bradley, H. Henry Lai, Mitchell B. Berger, Margaret G. Mueller, Jennifer A. Bickhaus, Vignesh T. Packiam, Dee Fenner, Brenda W. Gillispie, Ziya Kirkali

Research output: Contribution to journalReview articlepeer-review

25 Scopus citations


Purpose: Lower urinary tract symptoms are prevalent and burdensome, yet methods to enhance diagnosis and appropriately guide therapies are lacking. We systematically reviewed the literature for human studies of biomarkers associated with lower urinary tract symptoms. Materials and Methods: PubMed®, EMBASE® and Web of Science® were searched from inception to February 13, 2018. Articles were included if they were in English, performed in benign urological populations without neurological disorders or interstitial cystitis/bladder pain syndrome, and assessed a biomarker's association with or ability to predict specific lower urinary tract symptoms or urological conditions. Bioinformatic pathway analyses were conducted to determine whether individual biomarkers associated with symptoms are present in unifying pathways. Results: Of 6,150 citations identified 125 met the inclusion criteria. Most studies (93.6%) assessed biomarkers at 1 time point and were crosssectional in nature. Few studies adjusted for potentially confounding clinical variables or assessed biomarkers in an individual over time. No individual biomarkers are currently validated as diagnostic tools for lower urinary tract symptoms. Compared to controls, pathway analyses identified multiple immune response pathways that were enriched in overactive bladder syndrome and cell migration/cytoskeleton remodeling pathways that were enriched in female stress incontinence. Conclusions: Major deficiencies in the existing biomarker literature include poor reproducibility of laboratory data, unclear classification of patients with lower urinary tract symptoms and lack of adjustment for clinical covariates. Despite these limitations we identified multiple putative pathways in which panels of biological markers need further research.

Original languageEnglish
Pages (from-to)880-889
Number of pages10
JournalJournal of Urology
Issue number5
StatePublished - 2019


  • Biomarkers
  • Lower urinary tract symptoms
  • Nocturia
  • Overactive
  • Stress
  • Urinary bladder
  • Urinary incontinence


Dive into the research topics of 'Biomarkers implicated in lower urinary tract symptoms: Systematic review and pathway analyses'. Together they form a unique fingerprint.

Cite this